Pharmaceuticals / Biologics
BSL BIOSERVICE supports your project in all phases from early development to commercialization.
Our services during development include ADME, IND-enabling toxicology / PK studies, microbiology and clinical sample analysis. In late-phase and after market approval, BSL BIOSERVICE provides immunogenicity assessment and bioassays for batch release.
Complete IND Packages
BSL BIOSERVICE provides full nonclinical development programs in support of IND and later-stage regulatory submissions for new chemical (NCE) or biological entities (NBE). On the basis of more than 20 years of experience we are guiding your project with highest flexibility and efficiency to IND and beyond.